KAREN PERRY: Open Payments
NPI 1659547354 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 12 companies in 2025. Trend: 2023 $410 · 2024 $595 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Lilly USA, LLC | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Amgen Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Abbott Laboratories | 1 | $23 |
Products named: Kerendia, ELIQUIS, MOUNJARO, XIFAXAN, OTEZLA, SAPIEN 3 Ultra RESILIA, PREVNAR 20, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
